Top MBA Recruiters: GlaxoSmithKline
GlaxoSmithKline (GSK) is a multinational pharmaceutical company headquartered in London. As for 2015, it’s the sixth-largest pharmaceutical company in the world with annual revenue of £30.821 billion in 2018.
The company is listed on the London Stock Exchange, and as of 2016, it was the fourth-largest company with a market capitalization around £81 billion. It has a secondary listing on the New York Stock Exchange.
Some of its top-selling products include Advair, Avodart, Flovent, Abreva, Lovaza, Lamictal, and Nicoderm. GSK also has many legacy products listed as essential medicines by the World Health Organization, including amoxicillin, mercaptopurine, pyrimethamine, and zidovudine. Continue reading…
Announcing Saïd’s New Skoll Scholars, 2014-15
The Skoll Centre for Social Entrepreneurship at Saïd Business School is delighted to announce Skoll Scholars for the 2014-15 academic year. The four Scholars, who were selected as recipients of this highly competitive scholarship following a rigorous selection process, will commence MBA studies this fall:
– Nora Petty of Ann Arbor MI, USA, who spent the past seven years committed to ending malaria deaths with the Clinton Health Access Initiative and the Malaria Consortium
– Nikhil Nair of Hyderabad, Andhra Pradesh in India, who worked with rural markets and solar energy enterprises in India, the United Arab Emirates, and East Africa
– José Miguel Alfaro Gómez of San Jose, Costa Rica who founded s.e.e.d., a boutique law firm targeted to social businesses in Costa Rica in various fields like sustainability, conservation, microfinance, fair trade, culture, education, volunteering, health, sports and development.
– Patrick Beattie of Cambridge MA, USA who worked with Diagnostics For All (DFA), a nonprofit medical diagnostics development company, and increased its global reach.
